Marker promise for safer bone marrow transplants
This article was originally published in Clinica
Executive Summary
Levels of the protein tumour necrosis factor (TNF) measured one week after a bone marrow transplant could help doctors determine which patients are likely to develop a serious and deadly complication, making them candidates for preventive treatment before any symptoms occur.